Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05425615

Language Processing and TMS

This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location status: Recruiting

Location contact

Sidney Schoenrock, MS

CONTACT

[email protected]

414-955-7579

About this study

To examine the brain's structure and specific language function and interactive relationships, investigators will implement repetitive or rapid TMS protocols in an active (or sham)-controlled, within-subject, randomized studies. Aims will evaluate the effects of short-term changes on each of the semantic or phonological language process of interest in isolation and changes in the interaction between language sub-processes and their interaction with other cognitive domains that directly or indirectly affect language functions. The brain targets for TMS application will be informed by existing evidence on (correlational but not causal) associations between language regions and specific language processes from numerous prior neuroimaging (e.g., functional magnetic resonance imaging or fMRI) and neuropsychological studies. Healthy individuals and/or stroke survivors with aphasia will be recruited to address these aims.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with left hemisphere stroke
  • Consent date >= 1 month after stroke onset
  • Right-handed
  • Fluent in English
  • 18 years of age or older

Exclusion criteria

  • Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
  • Non-decisional per decisionality questionnaire or other clinical assessment
  • Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease)
  • A chronic medical condition that is not treated or is unstable
  • Presence of
  • cardiac stimulators or pacemakers or intracardiac lines
  • neurostimulators
  • medication infusion device
  • any other implants near the scalp (e.g., cochlear implants) or in the eye
  • metal in the body
  • Pregnancy
  • History of skull fractures, or skin diseases
  • History of ongoing or unmanaged seizures or a family history of epilepsy
  • Presence of factors that potentially decrease seizure thresholds
  • On pro-convulsant medications
  • Untreated Sleep deprivation or insomnia
  • Ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users)
  • History of dyslexia or other developmental learning disabilities

Treatment and study plan

Transcranial Magnetic Stimulation

Device

Deymed DuoMag XT-100 rTMS

Other names: TMS

Primary outcomes

  1. Reaction time on language task performance

    Time frame: Language tasks administered immediately before and/or after TMS administration (same day).

    Improvement on language task performance as measured by decrease in reaction time.

  2. Accuracy on language task performance

    Time frame: Language tasks administered immediately before and/or after TMS administration (same day).

    Improvement on language task performance as measured by increase in accuracy.

Study contacts

Contact information is provided by the study sponsor or research team.

Sidney Schoenrock

CONTACT

[email protected]

414-955-7579

Sponsors and collaborators

Lead sponsor

Medical College of Wisconsin

Other

Registry information

Official study title

Probing Language Processes Using Transcranial Magnetic Stimulation

Important dates

Study start
2024
Primary completion
2032
Study completion
2032
First posted
Jun 21, 2022
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.